Asia-Pacific Artificial Organs & Bionic Implants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Asia-Pacific Artificial Organs & Bionic Implants Market is segmented by Product (Artificial Organs, Bionics), and Geography

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2019
CAGR: 15.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Asia-Pacific Artificial Organs & Bionic Implants Market is expected to grow with a CAGR of 15.2% in the forecast period. The growth of the market in the country can be attributed to the increasing incidence of disabilities and technological advancements leading to the enhanced applications.

As the cases of disabilities are increasing, the demand for bionic implants is also increasing which are the substitutes having both mechanical and robotic elements that are used as prosthetics as a replacement for broken body parts such as hand, legs, limbs, etc. therefore the increasing trauma and accidents in the region is boosting the market growth. 

Furthermore, the increasing geriatric population who are more prone to organ failure is expected to boost the growth in the forecast period. According to the United Nations Population Fund 2019, one in four people in Asia and the Pacific will be over 60 years old by 2050. The geriatric population in the region will triple between 2010 and 2050, reaching close to 1.3 billion people. This increase in the trend of the population will help in boosting the overall market growth.

Scope of the report

As per the scope of the market, artificial organs and bionics are man-made devices that can be implanted or integrated in humans, to either replace a natural organ or provide support for the purpose of restoring specific function or a group of related functions, helping the patient to return to his normal life.

By Product
Artificial Organs
Artificial Heart
Artificial Kidney
Artificial Liver
Cochlear Implants
Vision Bionics
Ear Bionics
Orthopedic Bionic
Cardiac Bionics
South Korea
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

Key Market Trends

Orthopedic Segment is Expected to Have a Highest Growth Rate in the Forecast Period

The orthopedic segment is found increasing which is attributed to the increasing number of road accidents and injuries requiring amputation. In the report of road accidents by the Government of India, 2018, a total of 4,67,044 road accidents has been reported by States and Union Territories, in the calendar year 2018, claiming 1,51,417 lives and causing injuries to 4,69,418 persons. India ranks first in the number of road accidents followed by China.

According to the National Bureau of Statistics of China, the country has recorded 63,194 fatalities in traffic accidents across the country for the year 2018. According to Statistics Bureau Japan, in the year 2018, there were 3,532 deaths due to road accidents. Therefore, the increasing road and transport injuries are boosting the segment growth in the region.

In addition, the increasing amputations and the causes for those like road accidents and diabetes are also boosting the segment growth.

china accidents

Competitive Landscape

The Asia-Pacific Artificial Organs & Bionic Implants Market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Some of the major players are Ossur, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, Medtronic plc, Zimmer Biomet, Edwards Lifesciences Corporation.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased Incidence of Disabilities and Rising Number of Road accidents

      2. 4.2.2 Technological Advancements Leading to Enhanced Applications

    3. 4.3 Market Restraints

      1. 4.3.1 Expensive Procedures and Fear of Device Malfunction and its Consequences

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Artificial Organs

        1. Artificial Heart

        2. Artificial Kidney

        3. Artificial Liver

        4. Cochlear Implants

        5. Others

      2. 5.1.2 Bionics

        1. Vision Bionics

        2. Ear Bionics

        3. Orthopedic Bionic

        4. Cardiac Bionics

    2. 5.2 Geography

      1. 5.2.1 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific


    1. 6.1 Company Profiles

      1. 6.1.1 Ossur

      2. 6.1.2 Boston Scientific Corporation

      3. 6.1.3 Otto Bock Holding GmbH & Co. KG

      4. 6.1.4 Medtronic plc

      5. 6.1.5 Zimmer Biomet

      6. 6.1.6 Edwards Lifesciences Corporation

      7. 6.1.7 Sonova Holding AG

      8. 6.1.8 Abbott (St. Jude Medical, Inc.)

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia-Pacific Artificial Organs and Bionic Implants Market market is studied from 2018 - 2026.

The Asia-Pacific Artificial Organs and Bionic Implants Market is growing at a CAGR of 15.2% over the next 5 years.

Ossur, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, Medtronic plc, Zimmer Biomet are the major companies operating in Asia-Pacific Artificial Organs and Bionic Implants Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!